DNMT1 is a direct target of miR-30a-5p and miR-30c-5p, and the overexpression of miR-30a-5p and miR-30c-5p-inhibited DNMT1 promoted cisplatin sensitivity and partially reversed EMT in ovarian cancer cell lines [85]. This evidence concerns the gene DNMT1 and ovarian cancer.